MTUSD:PA:PA-BNP Paribas Easy ECPI Global ESG Med Tech UCITS ETF USD Capitalisation (USD)

ETF | Others |

Last Closing

USD 10.329

Change

-0.07 (-0.64)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.17 (-0.38%)

USD 66.11B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-1.20 (-0.23%)

USD 11.38B
WRD:PA HSBC ETFs Public Limited Compa..

-0.13 (-0.40%)

USD 9.27B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-2.03 (-0.84%)

USD 7.87B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-2.85 (-0.63%)

USD 7.28B
HHH:PA HSBC ETFs Public Limited Compa..

-0.12 (-0.23%)

USD 6.91B
WLD:PA Lyxor UCITS MSCI World D-EUR

-1.18 (-0.36%)

USD 6.48B
LCWD:PA Multi Units Luxembourg - Lyxor..

-0.06 (-0.33%)

USD 5.45B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-1.04 (-0.29%)

USD 4.39B
500U:PA Amundi Index Solutions - Amund..

-0.56 (-0.52%)

USD 4.25B

ETFs Containing MTUSD:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.73% 32% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.73% 34% F 45% F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike